Pulmonary function was evaluated by measuring functional residual capacity (FRC), CO2-rebreathing method, spirometry, and chest radiography before surgery, and up to the third postoperative day.
Pulmonary function was measured as percentage of predicted forced expiratory volume in one second (FEV1).
Pulmonary function was characterised by a moderate reduction in DLCO and normal dynamic lung volumes.
Albuterol use decreased significantly in the 14-session protocol and at a borderline level I the 8-session protocol, while pulmonary function was maintained.
In the postpoliomyelitis group, pulmonary function was mostly related to scoliotic angle, kyphotic angle, location of the uppermost vertebra of the scoliotic curve, and age.
Pulmonary function was highest in those whose WFA remained >10th percentile from age 3 to 6 (FEV1: 100 ± 19 % predicted) and lowest in those who remained <10th percentile (84 ± 21 % predicted).
All nodules suspected of lung metastases were successfully resected with adequate margins, and the decrease in pulmonary function was minimal compared with predicted postoperative forced vital capacity (FVC) and forced expiratory volume (FEV) 1.0 calculated by the numbers of subsegments.
In conclusion, we conducted bilateral stapler-based segmentectomies with the aid of VAL-MAP without any postoperative complications and the decrease of pulmonary function was within the range of prediction.
Pulmonary function was monitored pre-EVH and post-EVH at 5, 10, 15, and 20 min. Exhaled nitric oxide (FENO), a non-invasive measure of airway inflammation, was measured pre-EVH and at 30 min post-EVH.
Pulmonary function was measured invasively in a subset of rats 7 days after treatment with DA (n = 8) or vehicle (n = 4) using the FlexiVent mechanical ventilator and data acquisition system (SCIREQ, Montreal, PQ, Canada).
Pulmonary function was evaluated by spirometry.
